Full

1. Ведение больных с инфекциями, передаваемыми половым путем, и урогенитальными инфекциями: Клинические рекомендации. Российское обществодерматовенерологов и косметологов. М.: Деловой экспресс, 2012. 112 с.

2. CDC. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae. 2014. MMWR. Recommendations and reports:Morbidity and mortality weekly report. Recommendations and reports. Centers for Disease Control. Mar 14 2014; 63(RR-02): 1-19.

3. Шипицына Е.В., Шалепо К.В., Савичева А.М., Домейка М. Научные исследования по оптимизации методов лабораторной диагностики инфекций, передаваемых половым путем. Журнал акушерства и женских болезней. 2007; 5(56): 32-5.

4. CDC. Sexually Transmitted Diseases Guidelines; 2014; URL: http://www.cdc.gov/std/treatment/2014/2014-std-guidelines-peer-reviewers-08-20-2014.pdf.

5. European guideline for the management of Chlamydia trachomatis infections. 2015. URL http://www.iusti.org/regions/europe/pdf/2015/Chlamydia2015.pdf.

6. Landers D.V., Sweet R.L. Current trends in the diagnosis and treatment of tuboovarian abscess. Am. J. Obstet. Gynecol. 1985; 151: 1098-110.

7. Moore K.R., Smith J.S., Cole S.R., Dittmer D.P., Schoenbach V.J., Baird D.D. Chlamydia trachomatis Seroprevalence and Ultrasound-Diagnosed Uterine Fibroids ina Large Population of Young African-American Women. Am J Epidemiol. 2018; 187(2): 278-86. https://dx. doi.org/10.1093/aje/kwx231.

8. CDC. Sexually Transmitted Diseases Guidelines; 2014; URL: http://www.cdc.gov/std/treatment/2014/2014-std-guidelines-peer-reviewers-08-20-2014.pdf

9. Lau C.Y., Qureshi A.K. Azithromycin versus doxycycline for genital Chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002; 29:497-502.

10. Pitsouni E., Iavazzo C., Athanasiou S., Falagas M.E. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection duringpregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents. 2007; 30: 213-21.

11. Brocklehurst P., Rooney G. Interventions for treating genital chlamydia trachomatis infection in pregnancy. Cochrane Database of Systematic Reviews. 2007, Issue 4.Art. No.: CD000054. https://dx. doi.org/10.1002/14651858.CD000054.

12. Soltz-Szots J., Schneider S., Niebauer B., Knobler R.M., Lindmaier A. Significance of the dose of josamycin in the treatment of chlamydia infected pregnant patients.Z Hautkr. 1989; 64: 129-31.

13. Галимова Э.Р. Опыт лечения хламидийной урогенитальной инфекции у беременных вильпрафеном. Актуальные вопросы акушерства и гинекологии.2001-2002; 1(1).

14. Darville T. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis. 2005; 16: 235-44.

15. Wang Y., Yang W.B., Yuan H.Y., Zhang Q.X., Zhu X.Y. Analysis of the infection status and the drug resistance of mycoplasma and chlamydiae in genitourinary tractsof children with suspected nongonococcal urethritis. Zhonghua Er Ke Za Zhi. 2009 Jan; 47(1): 62-4.

16. Ведение больных с инфекциями, передаваемыми половым путем, и урогенитальными инфекциями: Клинические рекомендации. Российское обществодерматовенерологов и косметологов. М.: Деловой экспресс. 2012. 112 с.

17. CDC 2015 Sexually transmitted infections treatment guidelines. Pelvic Inflammatory Disease. URL: https://www.cdc.gov/std/tg2015/pid.htm.

18. European guideline for the management of Chlamydia trachomatis infections. Revision date: July 2010. (E. Lanjouw, J.M. Ossewaarde, A. Stary, F. Boag).

19. European Branch of the International Union against Sexually Transmitted Infections (IUSTI Europe) and the European Office of the World Health Organisation(WHO-Europe).